Clinical Evidence
254 results
HDx therapy enabled by Theranova
Reduction in all-cause hospitalization events seen in a randomized controlled trial comparing expanded hemodialysis vs. high-flux dialysis
PD
Remote Automated Peritoneal Dialysis Management in Colombia - Bunch Alfonso, et al.
PD
Remote Monitoring of Automated Peritoneal Dialysis Improves Personalization of Dialytic Prescription and Patient’s Independence. - Milan Manani et al.
PD
Remote monitoring of peritoneal dialysis: evaluating the impact of the Claria Sharesource system - Wood, et al.
PD
Remote Patient Management in Automated Peritoneal Dialysis: A Promising New Tool - Drepper V.
HDx therapy enabled by Theranova
Removal evaluation of a new dialyzers with medium cut-off membrane in HD treatments
HDx therapy enabled by Theranova
Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study
HDx therapy enabled by Theranova
Removal of Middle Molecules Using Medium Cut-Off Membranes in Hemodialysis Mode vs. High-Flux Membranes in Post-Dilutional Online Hemodiafiltration Mode: The REMOC Study
HDx therapy enabled by Theranova
Removal of middle molecules with medium cutoff dialyzer in patients on short frequent hemodialysis
HD
Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility - Grundström G, et al.
HDx therapy enabled by Theranova
Reply to “Comparison of four medium cut-off dialyzers”
HD
Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons - Hulko et al.
Vantive is a trademark of Vantive Health LLC or its affiliates.